Discover 1,948 paid clinical trials in Irving, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,948
Converting HR+ Breast Cancer Into an Individualized Vaccine
for
Breast Cancer
Location: Dallas TX, Houston TX, New York NY
Sponsor: Weill Medical College of Cornell University
Sex: Female
Age: 18 - 70+
Code: NCT03804944
Phase 2, Recruiting
A First-in-human (FIH), Phase 1 Study of ML261, an Autologous Potency Enhanced Anti-DLL3 CAR T Cell Therapy, in Participants With R/R SCLC or Select NECs (SPECTRAL-1)
for
Small Cell Lung Cancer (SCLC ),
Location: Dallas TX, Houston TX, St Louis MO, Nashville TN,
Sponsor: Moonlight Bio, Inc
Sex: All
Age: 18+
Code: NCT07488923
Phase 1, Recruiting
A Polypill for Acute Coronary Syndrome
for
Acute Coronary Syndrome
Location: Dallas TX
Sponsor: University of Texas Southwestern Medical Center
Sex: All
Age: 18+
Code: NCT07032389
Phase 2, Recruiting
A Clinical Study of Belzutifan (MK-6482) and Zanzalintinib in People With Renal Cell Carcinoma (RCC) (LITESPARK-034/LS-034/MK-6482-034)
for
Carcinoma, Renal Cell
Location: Dallas TX, Germantown TN, St Louis MO, Marietta GA,
Sponsor: Merck Sharp & Dohme LLC
Sex: All
Age: 18+
Code: NCT07489495
Phase 3, Recruiting
Trametinib and Everolimus for Treatment of Pediatric and Young Adult Patients With Recurrent Gliomas (PNOC021)
for
Recurrent World Health Organization (WHO) Grade II Glioma,
Location: Dallas TX, St Louis MO, Birmingham AL, Indianapolis IN,
Sponsor: University of California, San Francisco
Sex: All
Age: 1 - 25
Code: NCT04485559
Phase 1, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study to Assess Adverse Events and Change in Disease Activity of Multiple Treatment Combinations With Intravenous Mirvetuximab Soravtansine in Adult Participants With Ovarian Cancer
for
Ovarian Cancer
Location: Dallas TX, Fort Worth TX, Tyler TX, Abilene TX,
Location: Dallas TX, Houston TX, St Louis MO, Birmingham AL,
Sponsor: Cook Research Incorporated
Sex: All
Age: 18+
Code: NCT04875429
Recruiting
Evaluation of the Safety and Efficacy of Treatment w/High Dose Melphalan Given Directly Into the Liver Followed by Treatment w/Approved Cancer Treatment or Approved Cancer Treatment Alone in Patients w/ Metastatic Breast Cancer w/Liver Dominant Disease
for
Metastatic Breast Cancer in the Liver
Location: Dallas TX, Columbus OH, Tampa FL, Cleveland OH,
Sponsor: Delcath Systems Inc.
Sex: All
Age: 18+
Code: NCT06875128
Phase 2, Recruiting
DOC1021 Dendritic Cell Immunotherapy for Refractory Melanoma
for
Refractory Melanoma
Location: Dallas TX, Birmingham AL, Gilbert AZ, Scottsdale AZ,
Sponsor: Diakonos Oncology Corporation
Sex: All
Age: 18+
Code: NCT07288112
Phase 1, Phase 2, Recruiting
Integrated Therapies for Alcohol Use in Alcohol-associated Liver Disease (ITAALD) Trial
for
Alcohol-associated Hepatitis
Location: Dallas TX, Louisville KY, Indianapolis IN, Rochester MN,
Sponsor: Samer Gawrieh
Sex: All
Age: 18 - 70
Code: NCT07060638
Phase 2, Recruiting
Phase 2A/B Efficacy and Safety of Dabogratinib in Participants With Low Grade Upper Tract Urothelial Carcinoma
for
Low Grade Upper Tract Urothelial Carcinoma
Location: Dallas TX, Austin TX, Houston TX, St Louis MO,
Sponsor: Tyra Biosciences, Inc
Sex: All
Age: 18+
Code: NCT07265947
Phase 2, Recruiting
An International Observational Study of Adults With Acute Infection
for
Infectious Disease
Location: Dallas TX, Houston TX, Kansas City KS, Omaha NE,
Sponsor: University of Minnesota
Sex: All
Age: 18+
Code: NCT07069400
Recruiting
A Study to Evaluate Safety, Tolerability, and Efficacy of AB-1009 Gene Therapy (GAA Gene) in Adult Participants With Late-Onset Pompe Disease (PROGRESS-GT LOPD)
Location: Dallas TX, Oklahoma City OK, Jacksonville FL,
Sponsor: phenox Inc.
Sex: All
Age: 18+
Code: NCT07143019
Recruiting
Transgene Assay Testing Service of Tumor Samples From Patients Who Received a Bristol-Myers Squibb Manufactured Gene Modified Cell Therapy and Have a Qualifying Second Primary Malignancy